ABSTRACT… Objectives: To compare oral maternal hydration and intravenous infusion in women with third trimester isolated oligohydramnios in terms of mean change in amniotic fluid. Material & Methods: One hundred and fourteen pregnant females with singleton pregnancy, beyond 28 weeks gestation and AFI < 5cm were included. Placental insufficiency was ruled out on Doppler ultrasound of umbilical artery. Basal AFI and routine intake of fluid of all patients was noted. Patients were randomized either to receive oral maternal hydration or intravenous infusion. AFI measurement was repeated at 6th day after hydration therapy. Data was stratified for mean difference in improvement in amniotic fluid index. Results: One hundred and fourteen patients with mean age of 27.33 ± 3.87 years were included. 52 patients (45.6%) were primigravida and remaining 62 patients (54.4%) were multipara. Mean AFI value before treatment in sampled population was 3.35 ± 0.744 in oral hydration and 3.33 ± 0.787 in intravenous hydration (p=0.903). Mean AFI value after treatment was 5.53 ± 0.966 in oral hydration and 5.68 ± 1.490 in intravenous hydration, independent sample test showed non-significant (p=0.903) difference. Mean increase in AFI before and after treatment was cross tabulated and resultant difference was significant (p value=0.001). There is no effect of age, gestational age, history of oligohydramnios on improvement in amniotic fluid index. Conclusion: Both treatment modalities i.e. oral maternal hydration and intravenous infusion are effective in terms of improvement of amniotic fluid index but there is no difference in both treatments in pregnant females with isolated oligohydramnios in 3 rd trimester at current sample size.
INTRODUCTION
Amniotic fluid is a clear fluid that is present in amniotic sac and surrounds the fetus. Amnion, fetal skin, umbilical cord, kidneys and lungs contribute in the formation of amniotic fluid at different stages of fetal life and is removed by fetal swallowing. The amniotic fluid volume progressively increases to 1000ml by 38 weeks gestation and decreases thereafter to reach 350 ml by 42 weeks. 1 Amniotic fluid volume is measured by amniotic fluid index (AFI) and maximum vertical pool (MVP). AFI is an ultrasound estimation of amniotic fluid derived by adding together the deepest vertical pools, free of fetal parts, in four uterine quadrants. 2 Many factors may affect the amniotic fluid index including maternal blood volume, hydration status and maternal plasma osmolality. 3 Oligohydramnios is defined as amniotic fluid index less than 5 th centile for gestation, 2, 4 or an amniotic fluid index < 5cm or no pocket of amniotic fluid ≥2cm. 5 It is found in about 1-5% of the pregnancies. 3 Adequate amniotic fluid allows normal fetal movements and growth and cushions the fetus and umbilical cord. Oligohydramnios may inhibit these processes and can lead to fetal DOI: 10 2 limb defects, pulmonary hypoplasia, IUGR, cord compression, fetal distress, operative deliveries, meconium aspiration and stillbirth. 4, 6, 7 Oligohydramnios may be caused by fetal urinary tract abnormalities, uteroplacental insufficiency, fetal growth restriction, various drugs and rupture of membranes. 7, 8 Many studies have reported an increase in amniotic fluid index with maternal hydration in normal pregnancies and in pregnancies with oligohydramnios. Shahnazi et al. reported an increase in amniotic fluid index (from 4.70 to 6.25cm) after hydration with one liter of isotonic saline infusion. 3 However, in a recent Cochrane review, Hofmeyr et al. reported an increase in amniotic volume with oral (MD 1.35,95% confidence interval (CI) 1.43 to 2.60) as well as intravenous hypotonic hydration (MD 1.35, 95% CI 0.61 to 2.10), but no measureable effects were seen with intravenous isotonic hydration (MD 1.35.95% CI -0.67 to 0.67). 6 A study by Momina et al. compared oral and intravenous hydration in third trimester oligohydramnios and recorded an amniotic fluid index 7.48 ± 0.303 in oral group and 5.89 ± 0.373 in intravenous group after hydration. 4 Qureshi and Yusuf studied the effect of intravenous amino acid solution in isolated oligohydramnios and found it to be an effective therapy in raising AFI from mean pre-infusion AFI of 4.7cm to 5.8cm mean one week post infusion. 8 There is a lack of trials which have compared oral maternal hydration with intravenous infusions (intravenous amino acids and Hartmann's solution) in isolated oligohydramnios. The current study is performed to assess the effectiveness of oral hydration versus intravenous infusion in improving AFI whereby clarifying the role of these interventions in isolated oligohydramnios.
METHODOLOGY
The study was conducted in Department of Gynecology, Pakistan Institute of Medical Sciences, Islamabad, between 1 st May, 2015 to 31 st July, 2016. We randomly selected 114 patients in third trimester with isolated oligohydramnios (where maternal or fetal cause of oligohydramnios is not evident). The patients were recruited through OPD after taking written consent. Approval from our institute's Ethics Committee was obtained for the study.
Patients aged 20-40 years with singleton pregnancy more than 28 weeks gestation, with AFI less than 5cm were included. Exclusion criteria were premature rupture of membranes, antepartum hemorrhage, post-term pregnancy, congenital anomalies, multiple pregnancy, intrauterine growth restriction, labour, severe maternal comorbidites (pre-eclampsia, eclampsia, cardiovascular disorders, etc).
We calculated AFI according to the method of Phelan et al 9 , which added the maximum vertical fluid pocket (free of cord and fetal parts) taken in 4 uterine quadrants. AFI measurement was done by a single sonographer to avoid interobserver variability.
All study related information were collected on a pre-designed proforma. Demographic history was taken. Basal AFI and routine intake of fluid of all patients was noted. Placental insufficiency was ruled out on Doppler ultrasound of umbilical artery. By probability sampling technique patients were divided into two groups. Fifty seven patients in group A received treatment with 1.5 liters of oral fluids i.e. water, juices and tea and a similar number in group B received treatment with 500ml of intravenous amino acids (Panamin-G) and 1000ml of Hartmann's solution daily for 6 days, in addition to their normal routine fluid intake. The hydration therapy was carried out in daycare. AFI measurement was repeated at 6 th day after hydration therapy by the same sonographer. History of previous oligohydramnios was recorded additionally to cater for effect modification and data was stratified accordingly.
All the collected data was entered into SPSS version 16 and analyzed. Mean and standard deviation was calculated for age, parity and gestational age. The mean difference of amniotic fluid index of the two groups was compared by 3 an independent t-test. A p-value of < 0.05 will be considered statistically significant. Effect modifiers like age, gestational age, parity and history of oligohydramnios were controlled by stratification. Post-stratification independent sample t-test was applied.
RESULTS
In our study population 114 patients were included with mean age of 27.33 ± 3.876 ranged from 20 to 40 years of age, mean AFI score before treatment 3.34 ± 0.762 and after treatment 5.61 ± 1.252. (Table-I) 81 patients (71.1%) in our study population were below 30 years whereas 33 patients (28.9%) were either 30 years or more in age.
When sampled population was stratified by parity, 52 patients (45.6%) were primiparous and remaining 62 patients (54.4%) were multipara. Gestational age in 70 patients (61.4%) were below 38 weeks while in rest of 44 (38.9%) it was either 38 weeks or above.
Only 41 (36%) patients among sampled population had history of oligohydramnios.
Sampled population was equally distributed in two groups. Mean AFI value before treatment in sampled population was 3.35 ± 0.744 in oral hydration and 3.33 ± 0.787 in intravenous hydration while independent sample test appeared in non-significant results. (p=0.903).
Mean AFI value after treatment in sampled population was 5.53 ± 0.966 in oral hydration and 5.68 ± 1.490 in intravenous hydration, independent sample test showed non-significant. (p=0.503) difference. (Table-II) AFI before and after treatment was cross tabulated and resultant difference was significant (p value=0.001) on using paired sampled test. (Table-III) When age group was cross tabulated with difference in AFI results showed up with nonsignificant p value (p=0.48). Mean score for 81 patients below 30 years of age was -2.32 ± 1.312 and for above 30 years patients it was -2.12 ± 1.409. When parity was cross tabulated with difference in AFI results showed up with non-significant p value (p=0.708). Mean score difference for 52 primiparous patients was -2.21 ± 1.319 and for multipara patients it was -2.31 ± 1.362.
When gestation age was cross tabulated with difference in AFI results showed up with nonsignificant p value (p=0.712). Mean score for 70 patients below 38 weeks of gestation age was -2.30 ± 1.376 and for above 38 weeks it was -2.12 ± 1.286.
When history of oligohydramnios was cross tabulated with difference in AFI results showed up with non-significant p value (p=0.541). Mean score for 41 patients with history of oligohydramnios was -2.37 ± 1.299. Using independent sample test = 0.503 (non-significant) 
DISCUSSION
In our study, mean amniotic fluid index (AFI) score before treatment was 3.34 ± 0.762 and after treatment was 5.61 ± 1.25, resultant difference was significant(p value=0.001).
Mean AFI value after treatment in sampled population was 5.53 ± 0.966 in oral hydration and 5.68 ± 1.490 in intravenous hydration group. Resultant difference was statistically nonsignificant (p value > 0.05).
Our results are comparable with previous studies.
In a review, Hofmeyr et al. reported an increase in amniotic volume with oral hydration (MD 1.35, 95% confidence interval (CI) 1.43 to 2.60) as in our study. However no measureable effects were seen with intravenous isotonic hydration (MD 1.35.95% CI -0.67 to 0.67) which contradicts our study. 6 Shahnazi et al. reported an increase in amniotic fluid index (from 4.70 to 6.25cm) after hydration with one liter of isotonic saline infusion which is similar to our finding. 3 However our results are contradicted by a study of Momina et al. who compared oral and intravenous hydration in third trimester oligohydramnios and recorded an amniotic fluid index 7.48 ± 0.303 in oral group and 5.89 ± 0.373 in intravenous group after hydration, concluding that oral maternal hydration is more effective than I/V hydration. 4 Qureshi and Yusuf studied the effect of intravenous amino acid solution in isolated oligohydramnios and found it to be an effective therapy in raising AFI from mean pre-infusion AFI of 4.7cm to 5.8cm mean one week post infusion. 8 Patrelli and collegues studied effects of hydration on oligohydramnios by giving intravenous infusion of 1500 mL of an isotonic solution per day for 6 days followed by home oral hydration therapy of 1500 mL/d subgroup A1 and 2500 mL/d subgroup A2. They reported significant improvement in amniotic fluid index in both subgroups (P < .001). 7 In a study conducted by Nahid lorzadeh and collegues (2008), comparing oral and intravenous fluid therapy, oral hydration group (p<0.0001) had significant increase in AFI, but not in intravenous isotonic or hypotonic group which contradicts our results. 10 The mechanism responsible for change in amniotic fluid index after maternal hydration and the length of time the increase would persist is still unclear. After 24 weeks of pregnancy fetal urine output is a major contributor to amniotic fluid volume. By increasing intravascular volume and osmolaity, fetal diuresis can be increased. Different clinical studies suggest that the fetus can respond to changes in maternal intravascular volume or osmolality. 11, 12, 13 V.T.M. Borges and collegues found out that there was no significant difference between the oral isotonic solution and water in increasing the AF index in women with normohydramnios. Hydration with isotonic solution caused a 10-fold (95%CI: 2.09-49.89) and water 6-fold (95%CI: 15 Umber and chohan studied the effects of acute intravenous maternal hydration on amniotic fluid volume, by infusing 2 liters of 5% dextrose water in 2 hours. They found a significant (p<0.05) percentage increase in mean AFI i.e, 58.6% in the oligohydramnios group than the percentage increase of 28.4% in control group. 16 In a study by Shripad and collegues, 11 patients were given oral l-arginine and 39 patients received both arginine and intravenous hydration (500 ml of fructodex and lactated Ringer's solution daily) until the liquor improved significantly. The Improvement in liquor volume was significant after intervention with either or both l-arginine and fructodex infusion (P < 0.0001). 17 In our study we have found that both oral maternal hydration therapy and intravenous hydration are equally effective in increasing AFI. As there is prolonged hospital admission and risk of complications like thrombophlebitis and fluid overload with intravenous hydration therefore it is not preferred by many patients. So oral maternal hydration can be advised in such cases. Maternal hydration definitely plays an important role in improving amniotic fluid volume in patients with oligohydramnios.
CONCLUSION
Both treatment modalities i.e. oral maternal hydration and intravenous infusion are effective in terms of improvement of amniotic fluid index but there is no difference in both treatments in pregnant females with isolated oligohydramnios in 3 rd trimester at the current sample size. Copyright© 23 June, 2019.
